Skip to main content
Log in

Urinary androgen and 17-hydroxylated corticosteroid metabolites and their relation to recurrence rates in early breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The amounts of urinary androsterone and etiocholanolone are highly correlated with recurrence rates in patients with early breast cancer after treatment by mastectomy. A more efficient means of predicting the clinical course of the disease is obtained by using a ratio of these compounds to the amounts of individual 17-hydroxycorticosteroids in the urine. For instance, the ratio of androsterone to a-cortolone is particularly effective in identifying women with a high rate of recurrence, and this is largely independent of pathological stage and tumor grade.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bulbrook RD, Greenwood FC, Hayward JL: Selection of breast cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone. Lancet i: 21–32, 1960

    Google Scholar 

  2. Bulbrook RD, Hayward JL, Thomas BS: The relation between the urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids and the fate of patients after mastectomy. Lancet i: 945–947, 1964

    Google Scholar 

  3. Kodama M, Kodama T, Miura S, Yoshida M: Hormonal status of breast cancer. III. Further analysis of ovarianadrenal dysfunction. J Natl Cancer Inst 59: 49–54, 1977

    PubMed  Google Scholar 

  4. Thomas BS, Bulbrook RD, Hayward JL, Millis RR: Urinary androgen metabolites and recurrence rates in early breast cancer. Eur J Cancer Clin Oncol 18: 447–451, 1982

    PubMed  Google Scholar 

  5. Fantl V, Gray CH: Automated urinary steroid profiles by capillary gas-liquid chromatography and a computing integrator. Clin Chim Acta 79: 237–263, 1977

    PubMed  Google Scholar 

  6. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation on each patient. II. Analysis and examples. Brit J Cancer 35: 1–39, 1977

    PubMed  Google Scholar 

  7. Dorfman RI, Ungar F: Metabolism of Steroid Hormones. Academic Press, New York and London, 1965, p 592

    Google Scholar 

  8. Kumaoka S, Sakauchi N, Abe O, Kusama M, Takatani O: Urinary 17-ketosteroid excretion of women with advanced breast cancer. Jr. Clin Endocrinol 28: 667–672, 1968

    Google Scholar 

  9. Deshpande N: Enzyme studies in endocrine tissues.In Research on Steroids, Vol 4. Pergamon, 1977, pp 15–27

  10. Deshpande N, Jensen V, Carson P, Bulbrook RD, Doous TW: Adrenal function in breast cancer: biogenesis of androgens and cortisol by the human adrenal gland in vivo. J Endocrinol 47: 231–242, 1970

    PubMed  Google Scholar 

  11. Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K: A prognostic index in primary breast cancer. Brit J Cancer 45: 361–366, 1982

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, B.S., Bulbrook, R.D., Russell, M.J. et al. Urinary androgen and 17-hydroxylated corticosteroid metabolites and their relation to recurrence rates in early breast cancer. Breast Cancer Res Tr 4, 27–35 (1984). https://doi.org/10.1007/BF01806985

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806985

Keywords

Navigation